Titusville, NJ (April 28, 2006) –Beginning tomorrow, people of all ages with epilepsy are encouraged to submit original artwork to the Expressions of Courage® art contest. Sponsored by Ortho-McNeil Neurologics division of Ortho-McNeil-Janssen Pharamaceuticals, Inc., in partnership with the Epilepsy Foundation, the contest highlights the significant effect epilepsy can have on individuals and the courage many show in facing it.
"The contest is a great opportunity to recognize the ability of people who live with the challenges of epilepsy every day. Their courage and talent are remarkable," said Eric Hargis, president and CEO of the Epilepsy Foundation. "The quality of artwork we receive is exceptional and a clear demonstration that epilepsy doesn’t stand in the way of achievement."
People may submit original artwork that reflects their perspective on living with epilepsy. Artwork may be created in ink, pencil, crayon, marker, paint or any other flat medium, including computer-generated art. Entries will be accepted from April 29 through July 31, 2006, and should be mailed to: Expressions of Courage, c/o Ortho-McNeil Neurologics division of Ortho-McNeil-Janssen Pharamaceuticals, Inc., 389 Pittstown Road, Pittstown, NJ 08867.
A panel of judges will review the artwork and winning entries will be posted on the contest Web site and included in a calendar, coffee table book or note cards available at physician offices nationwide. Winners will be announced in November during National Epilepsy Awareness Month. Entry forms and more information can be found at www.expressionsofcourage.com or by calling
800-224-4935.
Epilepsy is a neurological condition that affects approximately 2.7 million Americans with nearly 200,000 newly diagnosed cases each year. Epilepsy can develop at any time in life, but there is a particular susceptibility in young children and the elderly. Seizures can be anything from a momentary disruption of the senses, to short periods of unconsciousness or staring spells, to convulsions. They are caused by a sudden change in how the cells of the brain send electrical signals to each other. Currently, there is no cure for epilepsy; however, seizure medications help control seizure activity in the majority of people with this condition.
In addition, Ortho-McNeil Neurologics Inc. has partnered with the Society for the Arts in Healthcare (SAH) to develop an exhibition titled "Expressions of Courage®: Through the Years." The new exhibit, featuring 21 pieces of art and personal stories about the artists, will be unveiled at SAH’s annual conference in Chicago and will be showcased at medical facilities nationwide.
"We believe that by showcasing the inspiring and beautiful artwork collected through the contest, we will help raise awareness of epilepsy and the Expressions of Courage contest as well as demonstrate the role art plays in peoples’ health care and daily lives," said Gay Hanna, PhD, MFA, executive director, Society for the Arts in Healthcare.
About the Epilepsy Foundation
The Epilepsy Foundation is a nonprofit organization with the goal of ensuring that people with seizures are able to participate in all life experiences, and works to prevent, control and cure epilepsy through research, education, advocacy and services. For more information, visit www.epilepsyfoundation.org.
About the Society for the Arts in Healthcare
The Society for the Arts in Healthcare (SAH) is a nonprofit organization
in Washington, D.C. Founded in 1991, SAH is dedicated to promoting the
incorporation of the arts as an integral component of health care. SAH
provides program development support through grants, consultant services
and the convening of conferences and symposia to a wide range of arts
and health care institutions nationally. For further information, visit
www.thesah.org
or call 202-299-9770.
About Ortho-McNeil Neurologics division of Ortho-McNeil-Janssen Pharamaceuticals, Inc.
Headquartered in Titusville, N.J., Ortho-McNeil Neurologics division of Ortho-McNeil-Janssen Pharamaceuticals, Inc. focuses exclusively on providing solutions that improve neurological health. The company currently markets products for Alzheimer's disease, epilepsy, and acute and preventive migraine treatment. Ortho-McNeil Neurologics division of Ortho-McNeil-Janssen Pharamaceuticals, Inc., in conjunction with internal and external research partners, continues to explore new opportunities to develop solutions for unmet health care needs in neurology.